Sunday 18 October 2026
Export GALT’s income statement to Excel — free account
Galectin Therapeutics Inc.
GALT Healthcare Biotechnology
In the quarter to June 2026, EPS fell 16.7%, free cash flow grew 63.1% and total debt fell 13.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
3.62
0.09
−2.43%
Follow GALT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.10 | 2.15 | 2.42 | 0.09 |
+8 more quarters Free account |
Net Debt/EBITDA |
(22.97) | (29.91) | (34.90) | (18.63) | |
Debt/Assets |
705.92% | 861.16% | 684.70% | 697.66% | |
Debt/Equity |
(0.76) | (1.04) | (1.06) | (0.73) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.27 | 0.76 | 1.09 | 0.43 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(1.99) | (2.05) | (1.74) | (2.31) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.04) | (0.06) | (0.09) | (0.06) | |
Cash per Share |
0.20 | 0.21 | 0.28 | 0.18 | |
Shareholders Equity per Share |
(2.08) | (1.98) | (1.97) | (1.92) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.08) | (1.98) | (1.97) | (1.92) | |
Free Cash Flow |
(2.44) | (3.87) | (6.04) | (3.54) | |
Working Capital |
(136.96) | 8.38 | 11.41 | (123.72) | |
Net Current Asset Value |
(137.02) | (130.30) | (126.29) | (123.72) | |
| Other line items | |||||
Quick Ratio |
0.09 | 1.93 | 2.21 | 0.08 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.04) | (0.06) | (0.09) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
4.80 | 4.83 | 4.45 | 4.09 | |
Average Assets |
15.21 | 12.64 | 18.51 | 20.92 | |
Average Common Equity |
(129.22) | (123.46) | (116.85) | (110.25) |
Columns are period end dates